Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where…
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named 'SARS-CoV-2'(severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named 'Coronavirus Disease 2019'(COVID-19). The outbreak of the respiratory disease was first detected in Wuhan…
The 2020 JP Morgan Healthcare Conference was loaded with insights from key pharma companies. An analysis of events and catalysts that were announced or updated at the conference these days are included. Our PharmaShots team summarized the key deals which were presented during the updates from companies from Jan 13 to Jan 16, 2020.
Date…
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it.
The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019.
PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…
The year 2019 has been a busy year for global pharma and biotech companies involved in M&A, option & licensing agreements and gaining approvals. Our team has compiled a list of 20 most read life sciences news on PharmaShots in 2019.
1. Celltrion Signed an Exclusive Co-Marketing Agreement with Juno in Australia
Juno provided sales promotion…
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…
The global pharma companies have been advancing their pipelines with emerging needs of patients. Pharma companies are also focusing on diagnostics & devices- which were emerged as one of major revenue generator in 2018- with the development of new products and devices. The year 2018 also proved to be a record with approval of 55…

